Dynastat
parecoxib
Table of contents
Overview
Dynastat is a painkilling medicine for use in adults for the short-term relief of pain after an operation.
It contains the active substance parecoxib.
This EPAR was last updated on 13/07/2020
Authorisation details
Product details | |
---|---|
Name |
Dynastat
|
Agency product number |
EMEA/H/C/000381
|
Active substance |
parecoxib sodium
|
International non-proprietary name (INN) or common name |
parecoxib
|
Therapeutic area (MeSH) |
Pain, Postoperative
|
Anatomical therapeutic chemical (ATC) code |
M01AH04
|
Publication details | |
---|---|
Marketing-authorisation holder |
Pfizer Europe MA EEIG
|
Revision |
30
|
Date of issue of marketing authorisation valid throughout the European Union |
22/03/2002
|
Contact address |
Product information
07/05/2020 Dynastat - EMEA/H/C/000381 - II/0077
Contents
- Annex I - Summary of product characteristics
- Annex IIA - Manufacturing-authorisation holder responsible for batch release
- Annex IIB - Conditions of the marketing authorisation
- Annex IIIA - Labelling
- Annex IIIB - Package leaflet
Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.
Pharmacotherapeutic group
Pharmacotherapeutic group
-
Antiinflammatory and antirheumatic products
-
Coxibs
Therapeutic indication
Therapeutic indication
For the short-term treatment of postoperative pain in adults.